Alpine Global Management’s CorMedix CRMD Stock Holding History

Alpine Global Management’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,000	Closed	-$79.3K	–	171
2023 Q2	$79.3K	Buy	+20,000	New	+$99K	0.02%	177
2020 Q4	–	Sell	-18,839	Closed	-$114K	–	234
2020 Q3	$114K	Buy	+18,839	New	+$94.6K	0.02%	183
2019 Q1	–	Sell	-2,139	Closed	-$14K	–	117
2018 Q4	$14K	Buy	+2,139	New	+$14.3K	﹤0.01%	232
2016 Q3	–	Sell	-5,513	Closed	-$55K	–	107
2016 Q2	$55K	Buy	+5,513	New	+$84K	0.03%	165

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Alpine Global Management's CRMD Position: Q3 2023 in Review

Alpine Global Management sold out of CorMedix (CRMD) in Q3 2023, closing a stake of 20,000 shares — an estimated $79.3K sold.

Alpine Global Management first reported a position in CRMD in Q2 2016 and held it in 4 quarters. The position peaked at $114K in Q3 2020. 92 funds tracked by Wall St. Rank hold CRMD as of Q3 2023.

Alpine Global Management reported no remaining CorMedix position as of Q3 2023 after selling out during the quarter.
Alpine Global Management sold 20,000 CorMedix shares in Q3 2023, an estimated $79.3K.
Alpine Global Management first reported a position in CorMedix in Q2 2016 and held it in 4 quarters.
Alpine Global Management's CorMedix position peaked at $114K in Q3 2020.
92 funds tracked by Wall St. Rank held CorMedix as of Q3 2023.

Based on Alpine Global Management's 13F filing for Q3 2023, filed 14 Nov 2023.